Security key
N69605108
Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS)
CUSIP: N69605108
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, par value Euro 0.12 per share
- Shares outstanding
- 65,237,679
- Total 13F shares
- 45,040,180
- Share change
- +100,912
- Total reported value
- $792,712,813
- Price per share
- $17.60
- Number of holders
- 60
- Value change
- +$1,806,103
- Number of buys
- 27
- Number of sells
- 17
Report period
Q2 2025
Institutions
60
Top holders
10
PHVS full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Pharvaris N.V. SEC filings
Pharvaris N.V. company facts
Broader feeds
Reporting periods
Holder history for CUSIP N69605108
Recent filing periods:
Top shareholders of PHVS - Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
3.8%
|
2,047,620
|
$51,436,214 | $0 | 30 Jun 2025 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Company |
12%
|
7,531,252
|
$118,240,656 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
8.3%
|
5,395,370
|
$84,707,309 | — | 31 Mar 2025 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
6.8%
|
4,410,581
|
$69,246,122 | — | 31 Mar 2025 | |
| venBio Partners LLC |
13F
|
Company |
6.6%
|
4,289,304
|
$67,342,073 | — | 31 Mar 2025 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
5.6%
|
3,653,310
|
$57,356,967 | — | 31 Mar 2025 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
5.1%
|
3,303,381
|
$51,863,082 | — | 31 Mar 2025 | |
| Venrock Adviser, LLC |
13F
|
Company |
4.8%
|
3,112,720
|
$48,869,704 | — | 31 Mar 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3.1%
|
2,017,464
|
$31,674,185 | — | 31 Mar 2025 | |
| Commodore Capital LP |
13F
|
Company |
2.9%
|
1,911,433
|
$30,009,498 | — | 31 Mar 2025 | |
| Novo Holdings A/S |
13F
|
Company |
2.6%
|
1,725,000
|
$27,082,500 | — | 31 Mar 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.2%
|
1,466,460
|
$23,023,422 | — | 31 Mar 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.2%
|
814,652
|
$12,790,036 | — | 31 Mar 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.2%
|
797,600
|
$12,522,320 | — | 31 Mar 2025 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1.2%
|
769,815
|
$12,086,096 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.96%
|
623,402
|
$9,787,411 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.91%
|
593,403
|
$9,316,427 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.9%
|
586,087
|
$9,202,000 | — | 31 Mar 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.59%
|
383,856
|
$6,026,539 | — | 31 Mar 2025 | |
| Patient Square Capital LP |
13F
|
Company |
0.38%
|
245,496
|
$3,854,287 | — | 31 Mar 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.34%
|
223,627
|
$3,510,944 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.3%
|
192,865
|
$3,027,981 | — | 31 Mar 2025 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
0.19%
|
126,995
|
$1,993,822 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.14%
|
93,784
|
$1,472,409 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
86,876
|
$1,363,953 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.12%
|
78,122
|
$1,226,515 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
75,365
|
$1,183,230 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.1%
|
68,331
|
$1,072,796 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.08%
|
52,574
|
$825,412 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.06%
|
40,978
|
$643,355 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
38,333
|
$601,828 | — | 31 Mar 2025 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.06%
|
36,633
|
$575,138 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
29,206
|
$458,533 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
28,174
|
$442,332 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
26,257
|
$412,235 | — | 31 Mar 2025 | |
| HighVista Strategies LLC |
13F
|
Company |
0.03%
|
22,768
|
$357,458 | — | 31 Mar 2025 | |
| Palumbo Wealth Management LLC |
13F
|
Company |
0.02%
|
14,102
|
$221,402 | — | 31 Mar 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
12,791
|
$200,819 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.02%
|
12,740
|
$200,018 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.02%
|
9,855
|
$154,724 | — | 31 Mar 2025 | |
| Virtus Investment Advisers, LLC |
13F
|
Company |
0.01%
|
8,636
|
$135,585 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
7,449
|
$116,949 | — | 31 Mar 2025 | |
| KLP KAPITALFORVALTNING AS |
13F
|
Company |
0.01%
|
5,800
|
$91,060 | — | 31 Mar 2025 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.01%
|
4,500
|
$70,650 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
2,861
|
$44,918 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,559
|
$40,176 | — | 31 Mar 2025 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0%
|
2,369
|
$37,193 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
2,278
|
$35,764 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
950
|
$14,915 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
543
|
$8,525 | — | 31 Mar 2025 |
Institutional Holders of Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS) as of Q2 2025
As of 30 Jun 2025,
Pharvaris N.V. - Ordinary Shares, par value Euro 0.12 per share (PHVS) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,040,180 shares.
The largest 10 holders included
GENERAL ATLANTIC, L.P., FMR LLC, Foresite Capital Management IV, LLC, venBio Partners LLC, VIKING GLOBAL INVESTORS LP, Bain Capital Life Sciences Investors, LLC, VR ADVISER, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., Commodore Capital LP, and NOVO HOLDINGS A/S.
This page lists
60
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
52
Q2 2025 holders
60
Holder diff
8
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.